LIBX-A402
Product Specifications
Target
Ferroptosis
Related Pathways
Apoptosis
Bioactivity
LIBX-A402 (Compound 15b) is a selective ACSL4 inhibitor with an IC50 of 0.33 μM. It notably safeguards MDA-MB-231 and LUHMES cells from ferroptosis. LIBX-A402 is applicable in research focused on cancer, ischemia-reperfusion injury, and neurodegenerative disorders such as Parkinson's disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1126722-01 0.02 mg (E-Coli)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details MBS1126722-02 0.1 mg (E-Coli)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details MBS1126722-03 0.02 mg (Yeast)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details MBS1126722-04 0.1 mg (Yeast)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details MBS1126722-05 0.02 mg (Baculovirus)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details MBS1126722-06 0.02 mg (Mammalian-Cell)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 1 (rnp1)
Sign In for Pricing
View Details